Home › Trial NCT04174781
Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC
- Trial IDNCT04174781
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorZhejiang University
- Enrollment61
- Start date2019-11-20
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.